Literature DB >> 34410562

Porphyromonas gingivalis outside the oral cavity.

Steeve Bregaint1, Emile Boyer1,2, Shao Bing Fong1, Vincent Meuric1,2, Martine Bonnaure-Mallet1,2, Anne Jolivet-Gougeon3,4.   

Abstract

Porphyromonas gingivalis, a Gram-negative anaerobic bacillus present in periodontal disease, is considered one of the major pathogens in periodontitis. A literature search for English original studies, case series and review articles published up to December 2019 was performed using the MEDLINE, PubMed and GoogleScholar databases, with the search terms "Porphyromonas gingivalis" AND the potentially associated condition or systemic disease Abstracts and full text articles were used to make a review of published research literature on P. gingivalis outside the oral cavity. The main points of interest of this narrative review were: (i) a potential direct action of the bacterium and not the systemic effects of the inflammatory acute-phase response induced by the periodontitis, (ii) the presence of the bacterium (viable or not) in the organ, or (iii) the presence of its virulence factors. Virulence factors (gingipains, capsule, fimbriae, hemagglutinins, lipopolysaccharide, hemolysin, iron uptake transporters, toxic outer membrane blebs/vesicles, and DNA) associated with P. gingivalis can deregulate certain functions in humans, particularly host immune systems, and cause various local and systemic pathologies. The most recent studies linking P. gingivalis to systemic diseases were discussed, remembering particularly the molecular mechanisms involved in different infections, including cerebral, cardiovascular, pulmonary, bone, digestive and peri-natal infections. Recent involvement of P. gingivalis in neurological diseases has been demonstrated. P. gingivalis modulates cellular homeostasis and increases markers of inflammation. It is also a factor in the oxidative stress involved in beta-amyloid production.
© 2021. The Society of The Nippon Dental University.

Entities:  

Keywords:  Bone; Brain; Cardiovascular; Gingipain; Lung; Porphyromonas gingivalis; Systemic disease; Virulence factor

Mesh:

Substances:

Year:  2021        PMID: 34410562     DOI: 10.1007/s10266-021-00647-8

Source DB:  PubMed          Journal:  Odontology        ISSN: 1618-1247            Impact factor:   2.634


  187 in total

1.  Porphyromonas gingivalis Capsule-Mediated Coaggregation as a Virulence Factor in Mixed Infection With Fusobacterium nucleatum.

Authors:  David Polak; Oren Ferdman; Yael Houri-Haddad
Journal:  J Periodontol       Date:  2016-11-25       Impact factor: 6.993

2.  The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence.

Authors:  Amrita Singh; Tiana Wyant; Cecilia Anaya-Bergman; Joseph Aduse-Opoku; Jorg Brunner; Marja L Laine; Michael A Curtis; Janina P Lewis
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

3.  A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification.

Authors:  Jack G Caton; Gary Armitage; Tord Berglundh; Iain L C Chapple; Søren Jepsen; Kenneth S Kornman; Brian L Mealey; Panos N Papapanou; Mariano Sanz; Maurizio S Tonetti
Journal:  J Periodontol       Date:  2018-06       Impact factor: 6.993

4.  A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells.

Authors:  T Njoroge; R J Genco; H T Sojar; N Hamada; C A Genco
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

5.  Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.

Authors:  N M O'Brien-Simpson; R A Paolini; B Hoffmann; N Slakeski; S G Dashper; E C Reynolds
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Mfa4, an Accessory Protein of Mfa1 Fimbriae, Modulates Fimbrial Biogenesis, Cell Auto-Aggregation, and Biofilm Formation in Porphyromonas gingivalis.

Authors:  Ryota Ikai; Yoshiaki Hasegawa; Masashi Izumigawa; Keiji Nagano; Yasuo Yoshida; Noriyuki Kitai; Richard J Lamont; Fuminobu Yoshimura; Yukitaka Murakami
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

7.  Novel fimbrilin PGN_1808 in Porphyromonas gingivalis.

Authors:  Keiji Nagano; Yoshiaki Hasegawa; Yasuo Yoshida; Fuminobu Yoshimura
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

8.  Combining culture and culture-independent methods reveals new microbial composition of halitosis patients' tongue biofilm.

Authors:  Sara Bernardi; Lamprini Karygianni; Andreas Filippi; Annette Carola Anderson; Andrea Zürcher; Elmar Hellwig; Kirstin Vach; Guido Macchiarelli; Ali Al-Ahmad
Journal:  Microbiologyopen       Date:  2019-11-14       Impact factor: 3.139

9.  The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts.

Authors:  Jorg Brunner; Nina Scheres; Nawal B El Idrissi; Dong M Deng; Marja L Laine; Arie J van Winkelhoff; Wim Crielaard
Journal:  BMC Microbiol       Date:  2010-01-11       Impact factor: 3.605

10.  Prevalence of Porphyromonas gingivalis fimA genotypes in the peri-implant sulcus of Koreans assessed using a new primer.

Authors:  Sung-Geun Kim; Ji-Youn Hong; Seung-Il Shin; Ji-Hoi Moon; Jin-Yong Lee; Yeek Herr
Journal:  J Periodontal Implant Sci       Date:  2016-02-15       Impact factor: 2.614

View more
  3 in total

1.  In vitro and in vivo study of the pathogenic role of PPARα in experimental periodontitis.

Authors:  Ying Chen; Zheqing Jiang; Ana Keohane; Yang Hu
Journal:  J Appl Oral Sci       Date:  2022-07-08       Impact factor: 3.144

2.  Unique Properties of Heme Binding of the Porphyromonas gingivalis HmuY Hemophore-like Protein Result from the Evolutionary Adaptation of the Protein Structure.

Authors:  Joanna Kosno; Klaudia Siemińska; Teresa Olczak
Journal:  Molecules       Date:  2022-03-05       Impact factor: 4.411

Review 3.  Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis.

Authors:  Ting Wang; Taichi Ishikawa; Minoru Sasaki; Toshimi Chiba
Journal:  Front Med (Lausanne)       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.